Sign in

CIK 0001035354

  • Non-accelerated filer
  • Smaller reporting company

Eloxx Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELOX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841368850
Phone
+1 781-577-5300
Business address
P.O. BOX 274, ARLINGTON, MA, 02476
Former names
Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Exercise or conversion Director acquired 37,695 shares (option exercise)
  8. 4 Shares withheld for taxes PRESIDENT AND CEO gave up 81,933 shares (to pay taxes)
  9. 4 Shares withheld for taxes HEAD OF R&D gave up 64,373 shares (to pay taxes)
  10. 4 Open-market buy INTERIM CFO bought 50,000 shares at $0.72 ($36,000)
  11. 4 Shares withheld for taxes COO, GENERAL COUNSEL &CORP SEC gave up 459 shares (to pay taxes)
  12. 4 Shares withheld for taxes COO, GENERAL COUNSEL &CORP SEC gave up 1,835 shares (to pay taxes)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 29 · 574 filings